Method of identifying responders to treatment with insulin sensitizers

Details for Australian Patent Application No. 2004289237 (hide)

International Classifications

Event Publications

1 June 2006 PCT application entered the National Phase

PCT publication WO2005/046734 Priority application(s): WO2005/046734

21 August 2008 Application Accepted

Published as AU-B-2004289237

6 November 2008 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 14 Oct 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2005

26 February 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 14 Oct 2008 2005

5 March 2009 Standard Patent Sealed

21 January 2010 Amendment Made

The nature of the amendment is: Amend the co-patentee name from Merck & Co., Inc. to Merck Sharp & Dohme Corp.

4 October 2012 Alteration of Name

The name of the patentee has been altered to Albert Einstein College of Medicine of Yeshiva University; Merck Sharp & Dohme Corp. 2005

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.